Zai Lab Ltd (ZLAB) stock
ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30471% above fair value
$24.60−1.44 (-5.53%)
Close on Nov 13, 2026Market cap $3.82BP/E –Yield –
Zai Lab cash
Cash and short-term investments held at the end of each period.
Zai Lab's cash was $559.66M at Sep 30, 2026. For fiscal 2025 it was $689.57M, down 11.6% from the year before. Over ten years it grew 48.6% a year on average. The highest annual figure on record is $1.41B in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $689.57M | -11.6% |
| FY2024 | Dec 31, 2024 | $779.67M | -3.3% |
| FY2023 | Dec 31, 2023 | $806.45M | -20.0% |
| FY2022 | Dec 31, 2022 | $1.01B | -28.4% |
| FY2021 | Dec 31, 2021 | $1.41B | +18.7% |
| FY2020 | Dec 31, 2020 | $1.19B | +330.1% |
| FY2019 | Dec 31, 2019 | $275.93M | +4.8% |
| FY2018 | Dec 31, 2018 | $263.30M | +14.6% |
| FY2017 | Dec 31, 2017 | $229.66M | +173.6% |
| FY2016 | Dec 31, 2016 | $83.95M | +537.9% |
| FY2015 | Dec 31, 2015 | $13.16M | +84.0% |
| FY2014 | Dec 31, 2014 | $7.15M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $559.66M | -22.0% |
| Q2 FY2026 | Jun 30, 2026 | $617.52M | -15.7% |
| Q1 FY2026 | Mar 31, 2026 | $661.32M | -12.7% |
| Q4 FY2025 | Dec 31, 2025 | $689.57M | -11.6% |
| Q3 FY2025 | Sep 30, 2025 | $717.16M | +16.4% |
| Q2 FY2025 | Jun 30, 2025 | $732.16M | +16.2% |
| Q1 FY2025 | Mar 31, 2025 | $757.26M | +16.4% |
| Q4 FY2024 | Dec 31, 2024 | $779.67M | -3.3% |
| Q3 FY2024 | Sep 30, 2024 | $616.09M | -24.9% |
| Q2 FY2024 | Jun 30, 2024 | $630.05M | -28.0% |
| Q1 FY2024 | Mar 31, 2024 | $650.78M | -30.1% |
| Q4 FY2023 | Dec 31, 2023 | $806.45M | -20.0% |
| Q3 FY2023 | Sep 30, 2023 | $820.41M | -26.7% |
| Q2 FY2023 | Jun 30, 2023 | $874.66M | -30.4% |
| Q1 FY2023 | Mar 31, 2023 | $930.39M | -29.1% |
| Q4 FY2022 | Dec 31, 2022 | $1.01B | -28.4% |
| Q3 FY2022 | Sep 30, 2022 | $1.12B | -28.6% |
| Q2 FY2022 | Jun 30, 2022 | $1.26B | -28.9% |
| Q1 FY2022 | Mar 31, 2022 | $1.31B | +29.5% |
| Q4 FY2021 | Dec 31, 2021 | $1.41B | +18.7% |
| Q3 FY2021 | Sep 30, 2021 | $1.57B | +791.8% |
| Q2 FY2021 | Jun 30, 2021 | $1.77B | +281.1% |
| Q1 FY2021 | Mar 31, 2021 | $1.01B | +178.7% |
| Q4 FY2020 | Dec 31, 2020 | $1.19B | +330.1% |
| Q3 FY2020 | Sep 30, 2020 | $175.88M | -45.1% |
| Q2 FY2020 | Jun 30, 2020 | $463.60M | +406.1% |
| Q1 FY2020 | Mar 31, 2020 | $363.58M | +38.1% |
| Q4 FY2019 | Dec 31, 2019 | $275.93M | +162.9% |
| Q3 FY2019 | Sep 30, 2019 | $320.31M | +39.5% |
| Q2 FY2019 | Jun 30, 2019 | $91.60M | +9.1% |
| Q4 FY2018 | Dec 31, 2018 | $263.30M | +1900.7% |
| Q3 FY2018 | Sep 30, 2018 | $104.96M | +1367.5% |
| Q4 FY2017 | Dec 31, 2017 | $229.66M | – |
| Q4 FY2016 | Dec 31, 2016 | $83.95M | – |
| Q4 FY2015 | Dec 31, 2015 | $13.16M | – |
| Q4 FY2014 | Dec 31, 2014 | $7.15M | – |
See a number that looks wrong?